Literature DB >> 17494094

Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome.

Annalisa Vilasi1, Pedro R Cutillas, Anthony D Maher, Severine F M Zirah, Giovambattista Capasso, Anthony W G Norden, Elaine Holmes, Jeremy K Nicholson, Robert J Unwin.   

Abstract

The renal Fanconi syndrome is a defect of proximal tubular function causing aminoaciduria and low-molecular-weight proteinuria. Dent's disease and Lowe syndrome are defined X-linked forms of Fanconi syndrome; there is also an autosomal dominant idiopathic form (ADIF), phenotypically similar to Dent's disease though its gene defect is still unknown. To assess whether their respective gene products are ultimately involved in a common reabsorptive pathway for proteins and low-molecular-mass endogenous metabolites, we compared renal Fanconi urinary proteomes and metabonomes with normal (control) urine using mass spectrometry and (1)H-NMR spectroscopy, respectively. Urine from patients with low-molecular-weight proteinuria secondary to ifosfamide treatment (tubular proteinuria; TP) was also analyzed for comparison. All four of the disorders studied had characteristic proteomic and metabonomic profiles. Uromodulin was the most abundant protein in normal urine, whereas Fanconi urine was dominated by albumin. (1)H-NMR spectroscopic data showed differences in the metabolic profiles of Fanconi urine vs. normal urine, due mainly to aminoaciduria. There were differences in the urinary metabolite and protein compositions between the three genetic forms of Fanconi syndrome: cluster analysis grouped the Lowe and Dent's urinary proteomes and metabonomes together, whereas ADIF and TP clustered together separately. Our findings demonstrate a distinctive "polypeptide and metabolite fingerprint" that can characterize the renal Fanconi syndrome; they also suggest that more subtle and cause-specific differences may exist between the different forms of Fanconi syndrome that might provide novel insights into the underlying mechanisms and cellular pathways affected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494094     DOI: 10.1152/ajprenal.00095.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  18 in total

Review 1.  Application of proteomic analysis to the study of renal diseases.

Authors:  Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

Review 2.  Rare inherited kidney diseases: challenges, opportunities, and perspectives.

Authors:  Olivier Devuyst; Nine V A M Knoers; Giuseppe Remuzzi; Franz Schaefer
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

3.  Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.

Authors:  Amira Shoukry; Shereen El-Arabi Bdeer; Rehab H El-Sokkary
Journal:  Mol Cell Biochem       Date:  2015-06-24       Impact factor: 3.396

Review 4.  Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction".

Authors:  Michael Ludwig; Sidharth K Sethi
Journal:  Int Urol Nephrol       Date:  2011-03-01       Impact factor: 2.370

5.  Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?

Authors:  Kathryn M Thrailkill; Chan-Hee Jo; Gael E Cockrell; Cynthia S Moreau; John L Fowlkes
Journal:  J Clin Endocrinol Metab       Date:  2010-10-13       Impact factor: 5.958

Review 6.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

Review 7.  Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology.

Authors:  Magda Bictash; Timothy M Ebbels; Queenie Chan; Ruey Leng Loo; Ivan K S Yap; Ian J Brown; Maria de Iorio; Martha L Daviglus; Elaine Holmes; Jeremiah Stamler; Jeremy K Nicholson; Paul Elliott
Journal:  J Clin Epidemiol       Date:  2010-01-08       Impact factor: 6.437

Review 8.  Inherited cerebrorenal syndromes.

Authors:  Scott J Schurman; Steven J Scheinman
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

9.  Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Authors:  Detlef Bockenhauer; Arend Bokenkamp; William van't Hoff; Elena Levtchenko; Joana E Kist-van Holthe; Velibor Tasic; Michael Ludwig
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 8.237

10.  Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations.

Authors:  Steven L Robinette; Elaine Holmes; Jeremy K Nicholson; Marc E Dumas
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.